Embecta (FRA:JX7) Ending Cash Position : €282 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Ending Cash Position?

Embecta's Ending Cash Position for the quarter that ended in Mar. 2024 was €282 Mil.

Embecta's quarterly Ending Cash Position declined from Sep. 2023 (€306 Mil) to Dec. 2023 (€274 Mil) but then increased from Dec. 2023 (€274 Mil) to Mar. 2024 (€282 Mil).

Embecta's annual Ending Cash Position increased from Sep. 2021 (€0 Mil) to Sep. 2022 (€334 Mil) but then declined from Sep. 2022 (€334 Mil) to Sep. 2023 (€306 Mil).

Embecta Ending Cash Position Historical Data

The historical data trend for Embecta's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Ending Cash Position Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Ending Cash Position

334.21

305.93

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial											323.54	292.96	305.93	273.91	281.98

Embecta Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Embecta's Ending Cash Position for the fiscal year that ended in Sep. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	310.054	+	-4.123
	=	306

Embecta's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	274.804	+	7.176
	=	282

Embecta Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Embecta's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta (FRA:JX7) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

EMBC:USA JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (FRA:JX7) Headlines

No Headlines